SNPs and breast cancer risk prediction for African American and Hispanic women

被引:0
作者
Richard Allman
Gillian S. Dite
John L. Hopper
Ora Gordon
Athena Starlard-Davenport
Rowan Chlebowski
Charles Kooperberg
机构
[1] Genetic Technologies Ltd.,Centre for Epidemiology and Biostatistics
[2] The University of Melbourne,Department of Medical Genetics
[3] Providence St. Joseph Medical Center/UCLA School of Medicine,Division of Public Health Sciences
[4] The University of Arkansas for Medical Sciences,undefined
[5] Fred Hutchinson Cancer Research Center,undefined
[6] Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center,undefined
来源
Breast Cancer Research and Treatment | 2015年 / 154卷
关键词
Single nucleotide polymorphisms; Breast cancer; Risk prediction; African American; Hispanic;
D O I
暂无
中图分类号
学科分类号
摘要
For African American or Hispanic women, the extent to which clinical breast cancer risk prediction models are improved by including information on susceptibility single nucleotide polymorphisms (SNPs) is unknown, even though these women comprise increasing proportions of the US population and represent a large proportion of the world’s population. We studied 7539 African American and 3363 Hispanic women from the Women’s Health Initiative. The age-adjusted 5-year risks from the BCRAT and IBIS risk prediction models were measured and combined with a risk score based on >70 independent susceptibility SNPs. Logistic regression, adjusting for age group, was used to estimate risk associations with log-transformed age-adjusted 5-year risks. Discrimination was measured by the odds ratio (OR) per standard deviation (SD) and the area under the receiver operator curve (AUC). When considered alone, the ORs for African American women were 1.28 for BCRAT, and 1.04 for IBIS. When combined with the SNP risk score (OR 1.23), the corresponding ORs were 1.39 and 1.22. For Hispanic women the corresponding ORs were 1.25 for BCRAT, and 1.15 for IBIS. When combined with the SNP risk score (OR 1.39), the corresponding ORs were 1.48 and 1.42. There was no evidence that any of the combined models were not well calibrated. Including information on known breast cancer susceptibility loci provides approximately 10 and 19 % improvement in risk prediction using BCRAT for African Americans and Hispanics, respectively. The corresponding figures for IBIS are approximately 18 and 26 %, respectively.
引用
收藏
页码:583 / 589
页数:6
相关论文
共 59 条
  • [1] Michailidou K(2013)Large-scale genotyping identifies 41 new loci associated with breast cancer risk Nat Genet 45 353-361
  • [2] Hall P(2008)Polygenes, risk prediction, and targeted prevention of breast cancer N Engl J Med 358 2796-2803
  • [3] Gonzalez-Neira A(2010)Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information J Natl Cancer Inst 102 1618-1627
  • [4] Pharoah PD(2011)Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women Breast Cancer Res Treat 127 479-487
  • [5] Antoniou AC(2013)Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model Breast Cancer Res Treat 139 887-896
  • [6] Easton DF(2014)Distribution of breast cancer risk from SNPs and classical risk factors in women of routine screening age in the UK Br J Cancer 110 827-828
  • [7] Mealiffe ME(2010)Performance of common genetic variants in breast-cancer risk models N Engl J Med 362 986-993
  • [8] Stokowski RP(2012)Evaluating breast cancer risk projections for Hispanic women Breast Cancer Res Treat 132 347-353
  • [9] Rhees BK(2007)Projecting individualized absolute invasive breast cancer risk in African American women J Natl Cancer Inst 99 1782-1792
  • [10] Comen E(2009)Breast cancer risk assessments comparing Gail and CARE models in African-American women Breast J 15 S72-S75